Green Cross Medical Science Corporation Net Assets

Latest as of June 2026: ₩56.08 Billion KRW ≈ $38.00 Million USD

Green Cross Medical Science Corporation net assets. Based on the latest financial reports, Green Cross Medical Science Corporation (142280) has net assets worth ₩56.08 Billion KRW (≈ $38.00 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩96.94 Billion ≈ $65.70 Million USD) and total liabilities (₩40.86 Billion ≈ $27.69 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 142280 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩56.08 Billion
% of Total Assets	57.85%
Annual Growth Rate	3.58%
5-Year Change	28.38%
10-Year Change	72.69%
Growth Volatility	67.92

Net Assets of Green Cross Medical Science Corporation (2014–2025)

Net assets of Green Cross Medical Science Corporation from 2014 to 2025. This chart illustrates how Green Cross Medical Science Corporation's net assets have evolved over time, based on quarterly financial data. See 142280 net asset quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Green Cross Medical Science Corporation (2014–2025)

The table below shows the annual net assets of Green Cross Medical Science Corporation from 2014 to 2025. For live market cap and overall valuation, see market cap of Green Cross Medical Science Corporation.

Year	Net Assets	Change
2025-12-31	₩46.37 Billion ≈ $31.42 Million	+12.50%
2024-12-31	₩41.21 Billion ≈ $27.93 Million	+11.62%
2023-12-31	₩36.92 Billion ≈ $25.02 Million	+11.03%
2022-12-31	₩33.25 Billion ≈ $22.54 Million	-7.92%
2021-12-31	₩36.11 Billion ≈ $24.47 Million	-36.04%
2020-12-31	₩56.47 Billion ≈ $38.27 Million	+13.90%
2019-12-31	₩49.58 Billion ≈ $33.60 Million	+223.18%
2018-12-31	₩15.34 Billion ≈ $10.40 Million	-33.97%
2017-12-31	₩23.23 Billion ≈ $15.75 Million	-13.46%
2016-12-31	₩26.85 Billion ≈ $18.20 Million	-6.99%
2015-12-31	₩28.87 Billion ≈ $19.56 Million	-8.37%
2014-12-31	₩31.50 Billion ≈ $21.35 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Green Cross Medical Science Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 26.6% over the analyzed period, indicating profitable operations and earnings retention.

Green Cross Medical Science Corporation Net Assets Breakdown (December 2025)

Green Cross Medical Science Corporation net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Retained Earnings	₩18.85 Billion	42.49%
Other Components	₩25.51 Billion	57.51%
Total Equity	₩44.36 Billion	100.00%

Green Cross Medical Science Corporation Competitors by Market Cap

The table below lists competitors of Green Cross Medical Science Corporation ranked by their market capitalization.

Company	Market Cap
Mondi PLC LSE:MNDI	$42.96 Million
OS Therapies Incorporated NYSE MKT:OSTX	$42.96 Million
Aureus Greenway Holdings Inc. NASDAQ:PUSA	$42.98 Million
Brand Group (M.G) Ltd TA:BRND	$42.99 Million
Mobileleader Co.Ltd KQ:100030	$42.95 Million
Oceanpal Inc NASDAQ:OP	$42.95 Million
Australian Vanadium Ltd AU:AVL	$42.94 Million
Adaptimmune Therapeutics plc F:473A	$42.94 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Green Cross Medical Science Corporation's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 41,214,438,830 to 44,358,636,420, a change of 3,144,197,590 (7.6%).
Net income of 3,666,195,480 contributed positively to equity growth.
Other factors decreased equity by 521,997,890.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩3.67 Billion	+8.26%
Other Changes	₩-522.00 Million	-1.18%
Total Change	₩-	7.63%

Book Value vs Market Value Analysis

This analysis compares Green Cross Medical Science Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.43x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 1.17x to 1.43x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩2482.17	₩2915.00	x
2017-12-31	₩2086.07	₩2915.00	x
2018-12-31	₩1377.33	₩2915.00	x
2019-12-31	₩2353.26	₩2915.00	x
2020-12-31	₩2680.28	₩2915.00	x
2021-12-31	₩1714.26	₩2915.00	x
2022-12-31	₩1577.38	₩2915.00	x
2023-12-31	₩1636.40	₩2915.00	x
2024-12-31	₩1898.68	₩2915.00	x
2025-12-31	₩2040.23	₩2915.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Green Cross Medical Science Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 8.26%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 3.38%
• Asset Turnover: 1.20x
• Equity Multiplier: 2.04x
Recent ROE (8.26%) is above the historical average (-11.37%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	11.80%	4.57%	1.56x	1.65x	₩566.58 Million
2015	2.53%	0.82%	1.23x	2.52x	₩-2.16 Billion
2016	-7.04%	-2.19%	1.35x	2.37x	₩-4.58 Billion
2017	-5.80%	-1.37%	1.63x	2.61x	₩-3.67 Billion
2018	-69.82%	-12.41%	1.35x	4.17x	₩-12.24 Billion
2019	-32.69%	-17.22%	1.06x	1.79x	₩-21.16 Billion
2020	11.90%	5.92%	1.07x	1.87x	₩1.07 Billion
2021	-58.71%	-20.85%	1.06x	2.65x	₩-24.81 Billion
2022	-10.77%	-3.17%	1.17x	2.90x	₩-6.91 Billion
2023	5.21%	1.91%	1.04x	2.62x	₩-1.65 Billion
2024	8.69%	3.45%	1.18x	2.13x	₩-540.37 Million
2025	8.26%	3.38%	1.20x	2.04x	₩-769.67 Million

Industry Comparison

This section compares Green Cross Medical Science Corporation's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $443,908,584,065
Average return on equity (ROE) among peers: 4.49%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Green Cross Medical Science Corporation (142280)	₩56.08 Billion	11.80%	0.73x	$42.95 Million
Dongwha Pharm.Co.Ltd (000020)	$401.68 Billion	1.39%	0.54x	$97.86 Million
Yuhan Corp. (000100)	$756.45 Billion	11.87%	0.32x	$3.90 Billion
Yuhan Corp Preferred (000105)	$2.01 Trillion	4.74%	0.23x	$45.29 Million
Yuyu Pharma (000220)	$123.37 Billion	-4.85%	0.58x	$40.69 Million
Yuyu Pharma Inc (000225)	$82.83 Billion	5.48%	0.47x	$12.97 Million
Yuyu Pharma Inc (000227)	$90.54 Billion	5.22%	0.52x	$28.23 Million
Ildong Holdings Co Ltd (000230)	$305.61 Billion	-6.28%	1.62x	$43.80 Million
Samil Pharm (000520)	$54.41 Billion	1.08%	0.83x	$110.35 Million
Donga Socio Holdings (000640)	$350.94 Billion	12.36%	1.19x	$383.95 Million
Jw Pharmac (001060)	$265.44 Billion	13.94%	1.43x	$353.00 Million

About Green Cross Medical Science Corporation

KQ:142280 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$42.95 Million

₩63.38 Billion KRW

Market Cap Rank

#22274 Global

#1414 in Korea

Share Price

₩2915.00

Change (1 day)

-0.51%

52-Week Range

₩2395.00 - ₩6230.00

All Time High

₩19450.00